Premier Technology Licensing Services for LifeScience Advancements
LICENSE
WHY
About 30% to 40% of healthcare startups, including those in MedTech, fail before they even make it to Series A funding.
Technical Feasibility: About 15-20% of medical device startups fail due to technical issues that could not be overcome.
​
Regulatory Hurdles: Around 25% of medical device startups face challenges with regulatory approval, leading to delays or failure.
The development of new Technology was at the heart of the business at its inception in 2015. It is in our Name.
​
Our strategy involves partnering with established healthcare and medical device companies, offering them a cutting-edge, licensable and verified technology that addresses critical issues while accelerating time to market by using our development services.
We are leveraging 80+ years of collective expertise in instrumentation, biosensor and point-of-care medical device design and development. To bring emerging technology to market under development partnerships.
OBJECTIVES
OUR
in development time.
30-40% Reduction
Accelerate Product Development Cycle
Objective: To reduce the time from concept to commercialization for medical device projects
100% success rate
in passing regulatory audits.
Enhance Regulatory Compliance and Quality Assurance
​
Objective: Ensure all development activities meet or exceed industry standards, specifically ISO 13485 and QMSR for medical devices.
15% MORE Patents
showcasing our commitment to innovation and excellence.
Foster Innovation through Collaboration
​
Objective: Utilize a collaborative approach to inspire innovation, facilitating the exchange of ideas and expertise between partners.
15-20% Cost Reduction
Efficient project management and optimization of development processes.
Optimize Resource Allocation and Cost Efficiency
​
Objective: Improve efficiency in the use of resources, including time, budget, and human capital, throughout the development process.
90% Customer Satisfaction
Incorporating user feedback into continuous product development cycles.
Strengthen Post-Market Support and Continuous Improvement
​
Objective: Provide ongoing support after market launch, focusing on post-market surveillance, feedback incorporation, and continuous product improvement.
APPROACH
OUR
Our Technology Block approach not only accelerates market penetration but also mitigates the risks and costs associated with direct market entry.
​
With strategic alignment and co-development with iDE8 you will be at the forefront of diagnostic technology innovation.
​
We offer significant value to our partners and stakeholders in a highly competitive market.
iDEATION
Create, develop and patent new technology with a focus on life science applications.
​
We Verify our technology for your intended use.
​
​
​
Co-Develop
Under commercial Development agreements.
From concept to validation, we Develop your products using our technology for partners application under the control of our ISO13485 Accredited Quality Management system.
iTERATATE
Acting independently or under commercial development agreements.
We create Iterative innovations and patent new technology for your future use.
​
​
Initial Development Intended Use
Partners contribute an initial investment to fund research, development, and prototyping stages for intended use.
​
Innovation Continuity: Clauses ensuring partners benefit from ongoing improvements and technological advancements.
PARTNER
OUR
Fast-track new product development with iDE8 for an unmatched edge in clinical diagnostics, environmental monitoring, and drug discovery and development.
Leverage our innovative solutions for enhanced accuracy and a competitive edge in a crowded patent landscape.
Our technology overcomes technical challenges related to sample volume, and measurement accuracy, which is crucial for devices like blood glucose meters and immunoassay systems.
Join us in setting new standards for precision and reliability, distinguishing your product line in the market.
6 months
Technology Feasibility
1-2 Years
Product Development
10 Years
Iterative Innovation and Sustaining
TECHNOLOGY
OUR
Novelty
Enhanced Volumetric control for biosensors for improved bio-sensor accuracy and precision.
Core Features
-
Enhanced DFM - Reduction in manufacturing process control.
​
-
Increased sensor accuracy.
Sectors
-
Medical Device
-
Agriculture
-
Food and Drink
-
Life Sciences
Patents
​
1 Granted
3 Pending
Application
-
Biosensors
Development Level
​
TRL 5